UPC APP 32590/2025

—

Case details: Status
—
Action
Procedural application
Category
Document Access (RoP262)
Parties: Claimants
Arbutus Biopharma Corporation
Respondents
Moderna, Inc.
Moderna Belgium S.R.L.
Moderna Denmark ApS
Moderna Sweden AB
Moderna Switzerland GmbH
Moderna Portugal Unipessoal LDA
ModernaTX, Inc.
Moderna Norway AS
Moderna Poland SP. Z.O.O.
Moderna Netherlands B.V.
Moderna Biotech UK Limited
Moderna Italy S.R.L.
Moderna Germany GmbH
Moderna France SASU
Moderna Biotech Spain SL
Reps: Ruben Laddé; Joachim Renken
Division: The Hague LD
Judges: —
Language: —
First decided: Aug 4, 2025

Decisions

2025-08-04
Application RoP262A
The Local Division The Hague issued a confidentiality order under R.262A RoP based on an agreement reached between Moderna entities and Arbutus Biopharma/Genevant, establishing a confidentiality club for technical information disclosed in infringement proceedings concerning mRNA vaccine patents.
Legal issues:Confidentiality order (R.262A RoP)Confidentiality clubProtection of trade secrets in patent proceedings

Documents